Incidence of in situ and invasive cutaneous melanomas during the pandemic
Source: Eurek Alert!, September 2023
About The Study: Researchers identified decreases of in situ and invasive melanoma diagnoses during 2020, which may reflect decreased skin cancer screening examinations or access to dermatologic care during the pandemic, both of which may lead to reduced melanoma diagnoses. This study adds to the current literature by highlighting that the relative increase in thick melanomas in 2020 was primarily associated with a marked decrease in thin melanomas, rather than an absolute increase in thicker melanomas.
Authors: Rebecca I. Hartman, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.